LACOSAMIDE TEVA 100 MG

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

LACOSAMIDE

Available from:

ABIC MARKETING LTD, ISRAEL

ATC code:

N03AX18

Pharmaceutical form:

FILM COATED TABLETS

Composition:

LACOSAMIDE 100 MG

Administration route:

PER OS

Prescription type:

Required

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Therapeutic area:

LACOSAMIDE

Therapeutic indications:

Lacosamide Teva is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.

Authorization date:

2020-03-16

Patient Information leaflet

PATIENT LEAFLET IN ACCORDANCE WITH THE
PHARMACISTS' REGULATIONS (PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s prescription only
LACOSAMIDE TEVA 50 MG
LACOSAMIDE TEVA 100 MG
LACOSAMIDE TEVA 150 MG
LACOSAMIDE TEVA 200 MG
FILM-COATED TABLETS
Composition
Each Lacosamide Teva film-coated tablet contains 50 mg, 100 mg,
150 mg or 200 mg lacosamide.
For information about inactive ingredients and allergens, see section
2 “Important information about some of the ingredients of this
medicine” and section 6 “Additional information”.
READ
THE
ENTIRE
LEAFLET
CAREFULLY
BEFORE
YOU
START
USING
THIS
MEDICINE. This leaflet contains concise information about this
medicine.
If you have any further questions, consult your doctor or pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it
on to others. It may harm them, even if it seems to you that their
illness
is similar to yours.
Epilepsy is an illness characterized by recurrent fits (seizures).
Lacosamide Teva is administered when the state of epilepsy in which
the fits are initially partial (involving only one side of the brain),
but
may develop into generalized fits (involving extensive areas on both
sides of the brain).
Treatment with Lacosamide Teva is long-term. Do not stop treatment
without
an
explicit
instruction
from
the
doctor.
Discontinuation
of treatment may cause a recurrence or worsening of disease
symptoms. See section “IF YOU STOP TAKING THE MEDICINE”.
1. WHAT IS THIS MEDICINE INTENDED FOR?
Lacosamide Teva is intended for use in adults, adolescents and
children aged 4 years and older.
Lacosamide Teva is indicated for the treatment of a certain type of
epilepsy characterized by the occurrence of “partial-onset seizure
with or without secondary generalization”.
Lacosamide Teva may be used alone or in combination with other
antiepileptic medicines.
Lacosamide Teva contains lacosamide, which belongs to a group
of medicines called “antiepileptic medicines”. These medicines are
used to treat epilepsy.
THER